Results 41 to 50 of about 1,581 (183)

Senotherapeutics for HIV and aging

open access: yesCurrent Opinion in HIV and AIDS, 2020
Purpose of review To summarize the state of chronic, treated HIV infection and its contribution to accelerated aging, and to evaluate recent research relevant to the study and treatment of aging and senescence. Recent findings Chronic treated HIV-1 infection is associated with ...
Matthew A, Szaniawski, Adam M, Spivak
openaire   +3 more sources

Meeting Report: Aging Research and Drug Discovery [PDF]

open access: yes, 2022
Aging is the single largest risk factor for most chronic diseases, and thus possesses large socioeconomic interest to continuously aging societies. Consequently, the field of aging research is expanding alongside a growing focus from the industry and ...
Ai, Ruixue   +77 more
core   +5 more sources

Exploring the perspectives of pharmaceutical experts and healthcare practitioners on senolytic drugs for vascular aging-related disorder: a qualitative study

open access: yesFrontiers in Pharmacology, 2023
Objective: The field of targeting cellular senescence with drug candidates to address age-related comorbidities has witnessed a notable surge of interest and research and development.
Li Ping Wong   +7 more
doaj   +1 more source

Dasatinib Attenuates Fibrosis in Keloids by Decreasing Senescent Cell Burden

open access: yesActa Dermato-Venereologica, 2023
Keloids are skin tumours caused by aberrant growth of dermal fibroblasts. Cellular senescence contributes to aging and various pathological conditions, including cancer, atherosclerosis, and fibrotic diseases.
Claudia C. Darmawan   +5 more
doaj   +1 more source

Senotherapeutics and Their Molecular Mechanism for Improving Aging

open access: yesBiomolecules & Therapeutics, 2022
Aging is defined as physiological dysfunction of the body and a key risk factor for human diseases. During the aging process, cellular senescence occurs in response to various extrinsic and intrinsic factors such as radiation-induced DNA damage, the activation of oncogenes, and oxidative stress.
Park, Jooho, Shin, Dong Wook
openaire   +2 more sources

Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies

open access: yesBiology, 2023
Cellular senescence is a state of irreversible growth arrest with profound phenotypic changes, including the senescence-associated secretory phenotype (SASP).
Amit K. Dey   +7 more
doaj   +1 more source

Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis

open access: yesDermatopathology, 2023
Cellular senescence is one of the important mechanisms of skin aging. In a recent study, we have shown that in patients with dermatoporosis, an extreme senescence condition of the skin, cells positive for p16Ink4a, a biomarker of senescence, were significantly increased in the epidermis.
Kaya, Aysin   +2 more
openaire   +4 more sources

Moving from an “anti-aging” paradigm toward the concept of “disease-free aging”: the role of senolytics in modern medicine [PDF]

open access: yesGeriatrics, Gerontology and Aging
Senescent cells increase with aging and are related to the promotion of inflammation and neoplasia through the senescence-associated secretory phenotype (SASP). These cells are closely related to the biological aging process and, most importantly, to age-
Ivan Aprahamian   +2 more
doaj   +1 more source

Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer [PDF]

open access: yes, 2022
Background: Prostate cancer (PCa) is an age-related malignancy in men with a high incidence rate. PCa treatments face many obstacles due to cancer cell resistance and many bypassing mechanisms to escape therapy.
Atri Roozbahani, Golnaz   +3 more
core   +2 more sources

Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis

open access: yesSeminars in Cell & Developmental Biology, 2020
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic lung disease characterized by progressive scarring of the lung tissue, leading to respiratory failure. There is no cure for IPF, and current anti-fibrotic treatments modestly arrest its further progression. IPF prevalence and incidence increase with age, which is a recognized risk factor.
Wolfgang, Merkt   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy